✉news ScienceBiology first seen 3 d ago, last 1 h ago, peak #1

Private equity turns its eye to bioconvergence

Original: Investing in the age of bioconvergence

Private equity publications are examining bioconvergence, the growing overlap between biology, technology and engineering, as a new frontier for investment. The coverage explores how converging fields such as biotech, AI and medical devices are creating fresh opportunities for investors, and how funds are positioning themselves to back companies working at the intersection of these disciplines.

Why now: Investors are increasingly looking at the intersection of biology and technology as a source of new deal opportunities.

PEI Private EquityBuyoutsbioconvergence

Open on news →

Evidence

• Investing in the age of bioconvergence · PEI Private Equity
• Investing in the age of bioconvergence · Buyouts

API: https://socialmediatrends-api.osmike.com/v1/trends/3262210